Activation of BDNF/TrkB/CREB pathway reduces hepatic gluconeogenesis, glucose levels, leptin and food intake, induces hepatic insulin signal transduction, elevates number of glycolytic fibers in the skeletal muscle and protects from pancreatic β cell loss in DM [48,50–52]. The gene discussed is CREB1; the disease is diabetes mellitus.